Analysis of commercial claims data covering approximately 50 million insured lives found GLP-1 users experienced: 44% fewer major cardiovascular-related hospitalizations 69% improvement in medical spend growth among diabetes-related GLP-1 users over 30 months 37% improvement in medical spend growth among weight-loss GLP-1 users over 18 months Researchers have also observed positive trends related to inflammatory conditions, cardiovascular disease, and other chronic health concerns
7 Global Presence Introduction P|ESG Approach Impact Ambitions Strategic investment and Direct markets Exclusive distribution agreement exclusive license agreement Exclusive license agreement 8 Introduction P|ESG Approach Products, Programs Impact & Pipeline Ambitions We currently have two marketed products and a diversified portfolio of product candidates in clinical development
It stimulates the underlying structure of the skin, encouraging the growth of collagen over time
n 12 , reports including the target drug without acute pancreatitis
IV Therapy for Migraines At Dr
Ketamine, a general anesthetic that is also effective for use in anxiety disorders Esketamine (Ketanest), a derivative of ketamine delivered intranasally, has been approved for intractable depression Agomelatine, a synthetic version of melatonin Oxytocin Etifoxine (Stresam) Neurostimulation techniques Repetitive transcranial magnetic stimulation Vagus nerve stimulation Transcranial magnetic stimulation Deep-brain stimulation What Dietary and Lifestyle Changes May Be Beneficial for Anxiety Disorders
